Literature DB >> 16249531

Restless legs syndrome and quality of sleep in type 2 diabetes.

Lívia A Lopes1, Camila de M M Lins, Vanessa G Adeodato, Diana P Quental, Pedro F C de Bruin, Renan M Montenegro, Veralice M S de Bruin.   

Abstract

OBJECTIVE: To investigate the presence of restless legs syndrome (RLS) and the quality of sleep in a population of type 2 diabetic patients. RESEARCH DESIGN AND METHODS: The study population was composed of 100 consecutive patients regularly attending a diabetes clinic at the University Hospital of the Federal University of Ceará. The subjects' quality of sleep was assessed by the Pittsburgh Sleep Quality Index, and excessive daytime sleepiness (EDS) was measured by the Epworth Sleepiness Scale. The RLS was diagnosed using the four minimum criteria defined by the International Restless Legs Syndrome Study Group. Other relevant clinical and laboratory parameters were obtained by interview and chart review.
RESULTS: RLS was found in 27% of patients. Poor sleep quality was present in 45% of cases and was associated with age (P = 0.04), peripheral neuropathy (P = 0.001), and RLS (P = 0.000). EDS was found in 26% of patients. Logistic regression analysis revealed an association between RLS and peripheral neuropathy (odds ratio 12.85 [95% CI 2.83-58.40], P = 0.001).
CONCLUSIONS: RLS is common in type 2 diabetic patients and can be a major cause of sleep disruption in these patients.

Entities:  

Mesh:

Year:  2005        PMID: 16249531     DOI: 10.2337/diacare.28.11.2633

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  37 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  Response to restless legs syndrome and diabetic neuropathy--commentary by Gemignani, et al.

Authors:  Giovanni Merlino; Anna Serafini; Gian Luigi Gigli
Journal:  Sleep       Date:  2008-08       Impact factor: 5.849

3.  Lack of Association between Genetic Risk Loci for Restless Legs Syndrome and Multimorbidity.

Authors:  András Szentkirályi; Henry Völzke; Wolfgang Hoffmann; Julianne Winkelmann; Klaus Berger
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

Review 4.  Effect of diabetes mellitus on sleep quality.

Authors:  Salim Surani; Veronica Brito; Asif Surani; Shekhar Ghamande
Journal:  World J Diabetes       Date:  2015-06-25

Review 5.  The Epidemiology of Sleep and Diabetes.

Authors:  Rachel P Ogilvie; Sanjay R Patel
Journal:  Curr Diab Rep       Date:  2018-08-17       Impact factor: 4.810

6.  Restless Legs Syndrome in Iranian People With Type 2 Diabetes Mellitus: The Role in Quality of Life and Quality of Sleep.

Authors:  Leila Modarresnia; Fatemeh Golgiri; Nahid Hashemi Madani; Zahra Emami; Kiarash Tanha
Journal:  J Clin Sleep Med       Date:  2018-02-15       Impact factor: 4.062

Review 7.  Metabolic consequences of sleep and circadian disorders.

Authors:  Christopher M Depner; Ellen R Stothard; Kenneth P Wright
Journal:  Curr Diab Rep       Date:  2014-07       Impact factor: 4.810

8.  A comparison of glycemic control, sleep, fatigue, and depression in type 2 diabetes with and without restless legs syndrome.

Authors:  Norma G Cuellar; Sarah J Ratcliffe
Journal:  J Clin Sleep Med       Date:  2008-02-15       Impact factor: 4.062

9.  The relationship between physical activity, restless legs syndrome, and health-related quality of life in type 2 diabetes.

Authors:  Thiago Medeiros da Costa Daniele; Veralice Meireles Sales de Bruin; Adriana Costa e Forte; Débora Siqueira Nobre de Oliveira; Clara Mota Randal Pompeu; Pedro Felipe Carvalhedo de Bruin
Journal:  Endocrine       Date:  2012-12-01       Impact factor: 3.633

10.  Evaluation of Cardiovascular Risk Factors and Restless Legs Syndrome in Women and Men: A Preliminary Population-Based Study in China.

Authors:  Yuqiong Liu; Gangqiong Liu; Ling Li; Jing Yang; Shengli Ma
Journal:  J Clin Sleep Med       Date:  2018-03-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.